Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences - 29 Year Stock Price History | USNA

Historical daily share price chart and data for USANA Health Sciences since 1995 adjusted for splits and dividends. The latest closing stock price for USANA Health Sciences as of November 14, 2024 is 39.44.
  • The all-time high USANA Health Sciences stock closing price was 136.25 on July 25, 2018.
  • The USANA Health Sciences 52-week high stock price is 54.81, which is 39% above the current share price.
  • The USANA Health Sciences 52-week low stock price is 34.15, which is 13.4% below the current share price.
  • The average USANA Health Sciences stock price for the last 52 weeks is 44.75.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
USANA Health Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 44.0995 54.4500 54.4500 34.4800 39.4400 -26.42%
2023 59.0943 54.4600 67.9200 44.4400 53.6000 0.75%
2022 71.1160 102.9400 102.9400 48.6600 53.2000 -47.43%
2021 96.8984 77.9500 106.4500 77.9500 101.2000 31.26%
2020 76.4390 77.9000 91.2000 45.7800 77.1000 -1.85%
2019 80.8571 116.5500 118.9700 58.9200 78.5500 -33.28%
2018 106.8860 74.9500 136.2500 70.7500 117.7300 58.99%
2017 61.8281 62.2000 75.6000 54.2500 74.0500 21.00%
2016 62.6045 63.6050 74.1250 47.4100 61.2000 -4.19%
2015 62.7007 51.1400 88.0600 48.9650 63.8750 24.52%
2014 39.3646 38.4700 59.0900 28.8100 51.2950 35.74%
2013 32.5806 16.4400 45.7050 16.4400 37.7900 129.52%
2012 20.2209 15.7650 24.6250 15.4600 16.4650 8.43%
2011 15.9897 21.8300 21.8300 11.8000 15.1850 -30.10%
2010 18.7135 16.2250 22.5350 12.3200 21.7250 36.21%
2009 14.2776 16.6800 18.4950 9.2950 15.9500 -6.83%
2008 15.9444 18.0500 24.7400 9.3150 17.1200 -7.66%
2007 22.2569 26.2300 30.8000 14.7400 18.5400 -28.22%
2006 21.1419 18.9150 26.2200 17.9550 25.8300 34.67%
2005 21.9370 16.9550 26.5400 16.5250 19.1800 12.16%
2004 14.7882 14.8950 18.2500 11.6650 17.1000 11.76%
2003 9.6598 2.9700 19.2000 2.9700 15.3000 407.88%
2002 1.3397 0.3625 3.0125 0.2900 3.0125 895.87%
2001 0.4610 0.3275 0.7200 0.3025 0.3025 -19.33%
2000 0.9648 1.1875 1.8750 0.3200 0.3750 -70.00%
1999 2.1249 2.5000 4.3125 1.0300 1.2500 -50.59%
1998 3.4142 2.2650 5.6875 2.1875 2.5300 11.70%
1997 2.0547 2.2650 2.6725 1.1563 2.2650 0.67%
1996 2.4225 1.3125 3.8750 1.0938 2.2500 59.99%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.769B $0.921B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.017B 30.41
Takeda Pharmaceutical (TAK) Japan $43.337B 9.02
Sandoz Group AG (SDZNY) Switzerland $19.524B 0.00
Merck (MKKGY) Germany $19.470B 17.44
Astellas Pharma (ALPMY) Japan $19.363B 17.83
United Therapeutics (UTHR) United States $16.217B 15.95
Summit Therapeutics (SMMT) United States $13.503B 0.00
Shionogi (SGIOY) Japan $12.119B 11.61
Neurocrine Biosciences (NBIX) United States $11.890B 31.49
Catalent (CTLT) United States $10.727B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.354B 7.19
Orion OYJ (ORINY) Finland $6.653B 18.71
Madrigal Pharmaceuticals (MDGL) United States $6.294B 0.00
Corcept Therapeutics (CORT) United States $5.431B 41.13
Ionis Pharmaceuticals (IONS) United States $5.422B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.075B 0.00
PTC Therapeutics (PTCT) United States $3.026B 0.00
Dyne Therapeutics (DYN) United States $2.889B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.622B 15.69
Catalyst Pharmaceuticals (CPRX) United States $2.457B 11.14
Arrowhead Pharmaceuticals (ARWR) United States $2.309B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.300B 0.00
Soleno Therapeutics (SLNO) United States $2.233B 0.00
Evotec AG (EVO) Germany $1.928B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.770B 0.00
Xencor (XNCR) United States $1.614B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.456B 0.00
Ocular Therapeutix (OCUL) United States $1.440B 0.00
Harrow (HROW) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Indivior (INDV) United States $1.354B 5.52
Guardian Pharmacy Services (GRDN) United States $1.300B 0.00
Cassava Sciences (SAVA) United States $1.295B 0.00
Enliven Therapeutics (ELVN) United States $1.193B 0.00
Ardelyx (ARDX) United States $1.177B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.163B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.050B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.21
Bioventus (BVS) United States $0.912B 28.82
Relay Therapeutics (RLAY) United States $0.854B 0.00
Cronos Group (CRON) Canada $0.768B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.674B 0.00
Tourmaline Bio (TRML) United States $0.650B 0.00
Exscientia (EXAI) United Kingdom $0.613B 0.00
Elite Pharmaceuticals (ELTP) United States $0.600B 0.00
Altimmune (ALT) United States $0.541B 0.00
Organogenesis (ORGO) United States $0.512B 0.00
Savara (SVRA) United States $0.511B 0.00
ProKidney (PROK) United States $0.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Zevra Therapeutics (ZVRA) United States $0.460B 0.00
OmniAb (OABI) United States $0.458B 0.00
Korro Bio (KRRO) United States $0.446B 0.00
Xeris Biopharma Holdings (XERS) United States $0.435B 0.00
Larimar Therapeutics (LRMR) United States $0.427B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.425B 172.14
Siga Technologies (SIGA) United States $0.424B 4.95
Esperion Therapeutics (ESPR) United States $0.418B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
4D Molecular Therapeutics (FDMT) United States $0.408B 0.00
Verve Therapeutics (VERV) United States $0.406B 0.00
Aquestive Therapeutics (AQST) United States $0.405B 0.00
Akebia Therapeutics (AKBA) United States $0.391B 0.00
Silence Therapeutics (SLN) United Kingdom $0.380B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.326B 0.00
Avita Medical (RCEL) United States $0.313B 0.00
Sage Therapeutics (SAGE) United States $0.312B 0.00
Lyell Immunopharma (LYEL) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.58
Aldeyra Therapeutics (ALDX) United States $0.251B 0.00
Pyxis Oncology (PYXS) United States $0.249B 0.00
Lexeo Therapeutics (LXEO) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.217B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.202B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.197B 0.00
Nanobiotix S.A (NBTX) France $0.185B 0.00
Heron Therapeutics (HRTX) United States $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.174B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
CytoDyn (CYDY) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.146B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Context Therapeutics (CNTX) United States $0.138B 0.00
Avalo Therapeutics (AVTX) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.110B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Century Therapeutics (IPSC) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Regulus Therapeutics (RGLS) United States $0.094B 0.00
Arch Biopartners (ACHFF) Canada $0.092B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
CASI Pharmaceuticals (CASI) China $0.082B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.28
ESSA Pharma (EPIX) Canada $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Scienture Holdings (SCNX) United States $0.069B 0.00
Metagenomi (MGX) United States $0.068B 0.00
AlloVir (ALVR) United States $0.066B 0.00
OptiNose (OPTN) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.057B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Protara Therapeutics (TARA) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Unicycive Therapeutics (UNCY) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Carisma Therapeutics (CARM) United States $0.037B 0.00
Citius Pharmaceuticals (CTXR) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
DURECT (DRRX) United States $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Oruka Therapeutics (ORKA) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
SHINECO (SISI) China $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
CERo Therapeutics Holdings (CERO) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.33
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 37.26